Key facts
- Swan Valley Medical’s last known valuation is $235.0M (Jul 2023).
- It has raised $36.1M across 2 recorded rounds; the latest was Seed Round ($931K) in Jul 2016.
- Swan Valley Medical has filed 10 Form Ds with the SEC since 2009, most recently Jul 2024 ($40K sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·Watchlist + deal alerts for Swan Valley Medical
Funding rounds
2 roundsAbout Swan Valley Medical
Developer of patented medical technologies designed to improve bladder management and patient care through safer surgical procedures. The company offers a urology instrument enabling suprapubic catheterization for incontinence, retention, and fluid management, along with hospital predictive data analytics, enabling healthcare providers to enhance safety, quantify clinical and economic outcomes, and reduce complications in critical care settings.
- Sector
- Healthcare
- HQ
- Bigfork, MT, United States
- Founded
- 2006
- Employees
- 7
- Website
- swanvalleymedical.com/
- Ownership
- Privately Held (backing)
Swan Valley Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Swan Valley Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Swan Valley Medical in its N-PORT filings yet. We sweep new filings monthly.